Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

CF Equities HAIG - Pharma

+ Add to Watchlist

CFEQPHB:LX

85.66 EUR 0.48 0.56%

As of 00:59:30 ET on 03/26/2015.

Snapshot for CF Equities HAIG - Pharma (CFEQPHB)

Year To Date: +15.44% 3-Month: +15.37% 3-Year: +10.47% 52-Week Range: 70.68 - 85.66
1-Month: +7.63% 1-Year: +12.16% 5-Year: +4.77% Beta vs LUXXX: 0.54

Mutual Fund Chart for CFEQPHB

No chart data available.
  • CFEQPHB:LX 85.66
  • 1M
  • 1Y
Interactive CFEQPHB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CFEQPHB

CF Equities HAIG - Pharma is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve the highest possible growth with its invested capital. The Fund invests primarily in equities of companies within the health industry. Pharmaceuticals, Health Services, Biotech, and the production of drugs are all possible sectors to be invested in worldwide.

Inception Date: 08-18-1999 Telephone: Tel +352 45 13 14 500
Managers: -
Web Site: www.haig.lu

Fundamentals for CFEQPHB

NAV (on 2015-03-26) 85.66
Assets (M) (on 2015-03-26) 5.35
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment -

Dividends for CFEQPHB

No dividends reported

Fees & Expenses for CFEQPHB

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 2.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 3.06

Top Fund Holdings for CFEQPHB

Filing Date: 01/30/2015
Name Position Value % of Total
M4E AG 172,920 538,473 9.448%
Burcon NutraScience Corp 211,764 496,241 8.707%
US DOLLAR SPOT 440 387,643 6.802%
Roche Holding AG 1,400 339,746 5.961%
4SC AG 310,000 260,400 4.569%
Mylan NV 4,500 217,836 3.822%
SYMTEX 8 12/03/18 350 202,913 3.560%
Valeant Pharmaceuticals Intern 1,400 199,430 3.499%
GlaxoSmithKline PLC 10,000 198,471 3.482%
Amgen Inc 1,400 193,083 3.388%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil